Qiang Du

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells”.

Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02586-9

N/A

0DataRank · unranked

102 citations

Leting Zheng, Qiang Du, Bing Yan, David A. Geller, Yihe Yan

MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1

Biochemical and Biophysical Research Communications(2020)10.1016/j.bbrc.2020.01.034

N/A

0DataRank · unranked

16 citations

Qiang Du, Xiao Cui, Peiqi Wan, Christof Kaltenmeier, Jing Luo +4 more

Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting β-catenin in mice

PLoS ONE(2020)10.1371/journal.pone.0239119

N/A

0DataRank · unranked

12 citations

Jing Luo, Christof Kaltenmeier, Qiang Du, Donna B. Stolz, Patricia Loughran +4 more

MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma

Translational Oncology(2020)10.1016/j.tranon.2020.100805

N/A

0DataRank · unranked

6 citations

Dachen Zhou, Qiang Du, Peiqi Wan, Kun Dong, Hui Hou +2 more

Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10/CXCR3 axis in hepatocellular carcinoma (HCC)

Cancer Letters(2021)10.1016/j.canlet.2021.03.002

N/A

0DataRank · unranked

96 citations

Leting Zheng, Qiang Du, Hamza O. Yazdani, Kun Dong, Yarong Guo +2 more

IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin

Translational Oncology(2021)10.1016/j.tranon.2021.101059

N/A

0DataRank · unranked

37 citations

Jun Xu, Qiang Du, Yihe Yan, David A. Geller, Yarong Guo